Literature DB >> 23752992

Prostate cancer: lymph node metastases: not always the same prognosis.

Riccardo Schiavina1, Eugenio Brunocilla.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23752992     DOI： 10.1038/nrurol.2013.127

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  9 in total

1.  Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients.

Authors:  L Bubendorf; A Schöpfer; U Wagner; G Sauter; H Moch; N Willi; T C Gasser; M J Mihatsch
Journal:  Hum Pathol       Date:  2000-05       Impact factor: 3.466

2.  The role of pelvic lymph node dissection during radical cystectomy for bladder cancer.

Authors:  Eugenio Brunocilla; Remigio Pernetti; Giuseppe Martorana
Journal:  Anticancer Res       Date:  2011-01       Impact factor: 2.480

3.  Tumor-induced activation of lymphatic endothelial cells via vascular endothelial growth factor receptor-2 is critical for prostate cancer lymphatic metastasis.

Authors:  Yiping Zeng; Kenneth Opeskin; Jeremy Goad; Elizabeth D Williams
Journal:  Cancer Res       Date:  2006-10-01       Impact factor: 12.701

4.  Prognostic value of lymphovascular invasion in bladder cancer in patients treated with radical cystectomy.

Authors:  Fabiano Palmieri; Eugenio Brunocilla; Alessandro Bertaccini; Mascia Guidi; Remigio Pernetti; Antonio Maria Morselli-Labate; Giuseppe Martorana
Journal:  Anticancer Res       Date:  2010-07       Impact factor: 2.480

5.  Long-term outcomes of patients with lymph node metastasis treated with radical prostatectomy without adjuvant androgen-deprivation therapy.

Authors:  Karim A Touijer; Clarisse R Mazzola; Daniel D Sjoberg; Peter T Scardino; James A Eastham
Journal:  Eur Urol       Date:  2013-04-10       Impact factor: 20.096

6.  Comparison of 18F-FACBC and 11C-choline PET/CT in patients with radically treated prostate cancer and biochemical relapse: preliminary results.

Authors:  Cristina Nanni; Riccardo Schiavina; Stefano Boschi; Valentina Ambrosini; Cinzia Pettinato; Eugenio Brunocilla; Giuseppe Martorana; Stefano Fanti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-04-17       Impact factor: 9.236

7.  Differing risk of cancer death among patients with lymph node metastasis after radical prostatectomy and pelvic lymph node dissection: identification of risk categories according to number of positive nodes and Gleason score.

Authors:  Riccardo Schiavina; Marco Borghesi; Eugenio Brunocilla; Fabio Manferrari; Michelangelo Fiorentino; Valerio Vagnoni; Alessandro Baccos; Cristian Vincenzo Pultrone; Giovanni Christian Rocca; Simona Rizzi; Giuseppe Martorana
Journal:  BJU Int       Date:  2013-01-17       Impact factor: 5.588

8.  Two positive nodes represent a significant cut-off value for cancer specific survival in patients with node positive prostate cancer. A new proposal based on a two-institution experience on 703 consecutive N+ patients treated with radical prostatectomy, extended pelvic lymph node dissection and adjuvant therapy.

Authors:  Alberto Briganti; Jeffrey R Karnes; Luigi Filippo Da Pozzo; Cesare Cozzarini; Andrea Gallina; Nazareno Suardi; Marco Bianchi; Massimo Freschi; Claudio Doglioni; Ferruccio Fazio; Patrizio Rigatti; Francesco Montorsi; Michael L Blute
Journal:  Eur Urol       Date:  2008-10-01       Impact factor: 20.096

9.  Pathological features of lymph node metastasis for predicting biochemical recurrence after radical prostatectomy for prostate cancer.

Authors:  Sigrid V Carlsson; Laura J Tafe; Daher C Chade; Daniel D Sjoberg; Niccolo Passoni; Shahrokh F Shariat; James Eastham; Peter T Scardino; Samson W Fine; Karim A Touijer
Journal:  J Urol       Date:  2012-10-22       Impact factor: 7.450
  9 in total
  1 in total

1.  Comparing nodal versus bony metastatic spread using tumour phylogenies.

Authors:  Stefano Mangiola; Matthew K H Hong; Marek Cmero; Natalie Kurganovs; Andrew Ryan; Anthony J Costello; Niall M Corcoran; Geoff Macintyre; Christopher M Hovens
Journal:  Sci Rep       Date:  2016-09-22       Impact factor: 4.379
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.